• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LSVT LOUD和EMST对帕金森病患者的影响:一项双臂非随机临床试验。

Effects of LSVT LOUD and EMST in individuals with Parkinson's disease: A two arm non-randomized clinical trial.

作者信息

Saleem Shakeela, Miles Anna, Allen Jacqueline

机构信息

Speech Science, School of Psychology, The University of Auckland, Auckland, New Zealand.

Department of Surgery, The University of Auckland, Auckland, New Zealand.

出版信息

Int J Speech Lang Pathol. 2025 Feb 3:1-15. doi: 10.1080/17549507.2025.2455635.

DOI:10.1080/17549507.2025.2455635
PMID:39895282
Abstract

PURPOSE

This study compared the effects of Lee Silverman Voice Treatment and Expiratory Muscle Strength Training on swallow, cough, and voice function in individuals with Parkinson's disease.

METHOD

Fifty-eight individuals with mild-moderate Parkinson's disease (male = 45, = 69 years, = 8) were enrolled in a two-treatment clinical trial and completed four consecutive weeks of either Lee Silverman Voice Therapy or Expiratory Muscle Strength Training. All participants completed standard protocol videofluoroscopic swallow study, spirometry-cough tests, acoustic-voice assessment, and self-rated questionnaires pre- and post-therapy. Data were analysed by masked clinicians using specialised software. Mixed-model repeated measures and t-tests were performed.

RESULT

Lee Silverman Voice Treatment resulted in greater effects in acoustic aerodynamic voice measures (loudness, pitch-range, and aerodynamic-efficiency;  < .05) compared to the Expiratory Muscle Strength Training group. There were significant effects on pharyngoesophageal segment maximum opening ( =.01) following Lee Silverman Voice Treatment. Expiratory Muscle Strength Training resulted in significantly greater change in maximum hyoid displacement (Hmax;  = .04) and decreased Hmax duration ( .01) compared to Lee Silverman Voice Therapy group. No cough measures and self-reported questionnaires significantly differed between groups with both groups improving post-treatment.

CONCLUSION

Both Lee Silverman Voice Therapy and Expiratory Muscle Strength Training improved specific swallow efficiency and airway defence capacity despite differences in task and therapeutic dose. Only Lee Silverman Voice Thearpy improved vocal intensity. Both treatments are feasible options for individuals with mild-moderate Parkinson's disease.

摘要

目的

本研究比较了李·西尔弗曼嗓音治疗(Lee Silverman Voice Treatment,LSVT)和呼气肌力量训练对帕金森病患者吞咽、咳嗽及嗓音功能的影响。

方法

58例轻中度帕金森病患者(男性45例,年龄=69岁,标准差=8)参与了一项双治疗临床试验,连续四周接受李·西尔弗曼嗓音疗法或呼气肌力量训练。所有参与者在治疗前后均完成了标准方案的电视荧光吞咽造影研究、肺活量咳嗽测试、声学嗓音评估及自评问卷。数据由盲法临床医生使用专业软件进行分析。采用混合模型重复测量和t检验。

结果

与呼气肌力量训练组相比,李·西尔弗曼嗓音治疗在声学空气动力学嗓音指标(响度、音高范围和空气动力学效率;P<0.05)上产生了更大的效果。李·西尔弗曼嗓音治疗后,咽食管段最大开口度有显著变化(P=0.01)。与李·西尔弗曼嗓音治疗组相比,呼气肌力量训练导致最大舌骨位移(Hmax;P=0.04)有显著更大的变化,且Hmax持续时间缩短(P<0.01)。两组咳嗽指标和自评问卷无显著差异,两组治疗后均有改善。

结论

尽管任务和治疗剂量存在差异,但李·西尔弗曼嗓音疗法和呼气肌力量训练均提高了特定的吞咽效率和气道防御能力。只有李·西尔弗曼嗓音疗法提高了嗓音强度。两种治疗方法都是轻中度帕金森病患者可行的选择。

相似文献

1
Effects of LSVT LOUD and EMST in individuals with Parkinson's disease: A two arm non-randomized clinical trial.LSVT LOUD和EMST对帕金森病患者的影响:一项双臂非随机临床试验。
Int J Speech Lang Pathol. 2025 Feb 3:1-15. doi: 10.1080/17549507.2025.2455635.
2
Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.李·西尔曼嗓音治疗(LSVT LOUD®)对帕金森病吞咽和咳嗽的影响:一项初步研究。
J Neurol Sci. 2017 Dec 15;383:180-187. doi: 10.1016/j.jns.2017.11.015. Epub 2017 Nov 15.
3
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.两种言语语言治疗方法对帕金森病患者言语问题的影响:PD COMM RCT。
Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001.
4
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.一项多中心、随机对照试验,旨在比较李·西尔弗曼嗓音治疗与标准国民保健制度语音和语言治疗与对照组在帕金森病中的临床和成本效益:一项随机对照试验的研究方案。
Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7.
5
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.李·西尔弗曼语音治疗与英国国民保健制度(NHS)言语和语言治疗对照治疗帕金森病(PD COMM)患者构音障碍的实用性、基于英国、多中心、三臂、平行组、非盲、随机对照试验。
BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341.
6
Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis.李·西尔弗曼嗓音治疗法(LSVT-BIG)改善帕金森病患者运动功能的系统评价和荟萃分析。
Clin Rehabil. 2018 May;32(5):607-618. doi: 10.1177/0269215517734385. Epub 2017 Oct 5.
7
Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.李·西尔弗曼嗓音治疗法(LSVT LOUD)对进行性核上性麻痹患者吞咽功能的影响:一项初步研究。
Prog Rehabil Med. 2021 Feb 20;6:20210012. doi: 10.2490/prm.20210012. eCollection 2021.
8
Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.多发性硬化症患者强化嗓音治疗(李·西尔弗曼嗓音治疗 [LSVT LOUD])的效果:一项初步研究。
J Voice. 2022 Jul;36(4):585.e1-585.e13. doi: 10.1016/j.jvoice.2020.07.025. Epub 2020 Aug 18.
9
Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.针对帕金森病患者的李·西尔弗曼嗓音治疗:常规诊所的疗效审计
Int J Lang Commun Disord. 2015 Mar-Apr;50(2):215-25. doi: 10.1111/1460-6984.12132. Epub 2014 Dec 3.
10
The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.李西尔曼嗓音治疗(LSVT LOUD®)对嗓音、交流和参与度的影响:来自前瞻性、纵向研究的结果。
J Commun Disord. 2021 Jan-Feb;89:106031. doi: 10.1016/j.jcomdis.2020.106031. Epub 2020 Aug 18.